5-17 | Médecins Sans Frontières/Doctors Without Borders (MSF) are pleased that, having shared the results of TB-PRACTECAL, our clinical trial that found a new, safer and more effective six-month oral treatment regimen for multi drug-resistant tuberculosis (MDR-TB), the World Health Organization (WHO) have announced it will update global guidance on treatment. Following the results of MSF’s trial the WHO are now recommending programmatic use of the 6- month BPaLM regimen – comprising bedaquiline, pretomanid, linezolid (600 mg) and moxifloxacin in MDR-TB patients in pla
5-4 | The COVID-19 vaccine Humanitarian Buffer (HB) is failing its mission to support people hit by the pandemic and struggling to access immunisation, says Médecins Sans Frontières (MSF). The HB is part of the COVAX mechanism*, whose aim is to assist groups of people who do not have access to COVID-19 vaccination in situations of humanitarian emergency. However, MSF’s recent experience in northern Syria has highlighted the system’s limitations and ultimate failure to fulfil its purpose.
2-26 | Médecins Sans Frontières (MSF)'s statement on the escalating situation in Ukraine.
2-26 | Médecins Sans Frontières (MSF)'s statement on the escalating situation in Ukraine.
1-27 | Nine Médecins sans frontières / Doctors Without Borders (MSF) staff members were detained by the Sudanese authorities in the capital Khartoum on the evening of 24 January, before being released the following morning.
Pages
Do Something
Field worker
I LIKE MSF
